Photodynamic therapy (PDT) of cancer and of various other conditions continues to gain clinical acceptance. The approvals of three photosensitizing drugs, Photofrin, Visudyne and Levulan, in the United States and the ongoing clinical evaluation of several promising new agents throughout the world provide the context for ongoing laboratory studies that are designed to understand further and to optimize this therapy. During the past several years, the field has gained a deeper appreciation of the complex and dynamic interactions among the photosensitizing drug, light, and oxygen that together define the dosimetry of PDT. Research in this laboratory has been directed at defining quantitatively the consequences of therapy-induced, photochemical oxygen consumption for therapeutic outcome. A critically important aspect of this effort is to define more precisely and in a manner that can be translated into clinically relevant measurements the relationship between the photodegradation of the sensitizing drug, the PDT-induced consumption of oxygen, the detailed deposition of photodynamic dose and the biological response. This in turn requires improved methods for performing and analyzing results from fluorescence spectroscopy in tumors and for the noninvasive assessment of tumor oxygenation. Toward these general ends, the application poses the following three specific aims: (1) to expand the experimental investigation and theoretical analysis of the oxygen problem in PDT; (2) to establish the ability of sensitizer fluorescence spectroscopy to report biological response of tumors in vivo and to investigate the feasibility of simultaneous spectroscopic assessment of blood oxygen, NADH and sensitizer bleaching/photoproduct kinetics from spatially resolved measurements of fluorescence; and (3) to determine the PDT threshold dose for induction of specific genes and the specific severity and duration of PDT-induced hypoxia required to induce the expression of hypoxia-inducible factor-10c. The experimental methods that will be used to accomplish these aims include the use of O2-sensitive microelectrodes, laser scanning optical sectioning fluorescence microscopy and microspectrofluorimetry, fluorescence spectroscopy in vivo and diffuse reflectance absorption spectroscopy. ? ?

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
2R01CA068409-09
Application #
6580687
Study Section
Radiation Study Section (RAD)
Program Officer
Stone, Helen B
Project Start
1995-07-01
Project End
2007-02-28
Budget Start
2003-03-01
Budget End
2004-02-29
Support Year
9
Fiscal Year
2003
Total Cost
$366,084
Indirect Cost
Name
University of Rochester
Department
Radiation-Diagnostic/Oncology
Type
Schools of Dentistry
DUNS #
041294109
City
Rochester
State
NY
Country
United States
Zip Code
14627
Baran, Timothy M (2015) Cylindrical diffuser axial detection profile is dependent on fiber design. J Biomed Opt 20:040502
Wojtovich, Andrew P; Foster, Thomas H (2014) Optogenetic control of ROS production. Redox Biol 2:368-76
Baran, Timothy M; Foster, Thomas H (2014) Comparison of flat cleaved and cylindrical diffusing fibers as treatment sources for interstitial photodynamic therapy. Med Phys 41:022701
Haidaris, Constantine G; Foster, Thomas H; Waldman, David L et al. (2013) Effective photodynamic therapy against microbial populations in human deep tissue abscess aspirates. Lasers Surg Med 45:509-16
Baran, Timothy M; Fenn, Michael C; Foster, Thomas H (2013) Determination of optical properties by interstitial white light spectroscopy using a custom fiber optic probe. J Biomed Opt 18:107007
Mitra, Soumya; Modi, Kshitij D; Foster, Thomas H (2013) Enzyme-activatable imaging probe reveals enhanced neutrophil elastase activity in tumors following photodynamic therapy. J Biomed Opt 18:101314
Baran, Timothy M; Foster, Thomas H (2013) Recovery of intrinsic fluorescence from single-point interstitial measurements for quantification of doxorubicin concentration. Lasers Surg Med 45:542-50
Snell, Sara B; Foster, Thomas H; Haidaris, Constantine G (2012) Miconazole induces fungistasis and increases killing of Candida albicans subjected to photodynamic therapy. Photochem Photobiol 88:596-603
Baran, Timothy M; Wilson, Jeremy D; Mitra, Soumya et al. (2012) Optical property measurements establish the feasibility of photodynamic therapy as a minimally invasive intervention for tumors of the kidney. J Biomed Opt 17:98002-1
Baran, Timothy M; Foster, Thomas H (2012) Fluence rate-dependent photobleaching of intratumorally administered Pc 4 does not predict tumor growth delay. Photochem Photobiol 88:1273-9

Showing the most recent 10 out of 61 publications